The Experts below are selected from a list of 52407 Experts worldwide ranked by ideXlab platform

Glenn R Gibson - One of the best experts on this subject based on the ideXlab platform.

  • the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of synbiotics
    Nature Reviews Gastroenterology & Hepatology, 2020
    Co-Authors: Kelly S Swanson, Glenn R Gibson, Gregor Reid, Karen P Scott, Robert W Hutkins, Raylene A Reimer, Kristin Verbeke, Hannah D Holscher, Meghan B Azad, Nathalie M Delzenne
    Abstract:

    In May 2019, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened a panel of nutritionists, physiologists and microbiologists to review the definition and scope of synbiotics. The panel updated the definition of a synbiotic to "a mixture comprising live microorganisms and substrate(s) selectively utilized by host microorganisms that confers a health benefit on the host". The panel concluded that defining synbiotics as simply a mixture of probiotics and Prebiotics could suppress the innovation of synbiotics that are designed to function cooperatively. Requiring that each component must meet the evidence and dose requirements for probiotics and Prebiotics individually could also present an obstacle. Rather, the panel clarified that a complementary synbiotic, which has not been designed so that its component parts function cooperatively, must be composed of a probiotic plus a prebiotic, whereas a synergistic synbiotic does not need to be so. A synergistic synbiotic is a synbiotic for which the substrate is designed to be selectively utilized by the co-administered microorganisms. This Consensus Statement further explores the levels of evidence (existing and required), safety, effects upon targets and implications for stakeholders of the synbiotic concept.

  • Probiotics and Prebiotics in intestinal health and disease: from biology to the clinic
    Nature Reviews Gastroenterology & Hepatology, 2019
    Co-Authors: Mary Ellen Sanders, Glenn R Gibson, Gregor Reid, Daniel J. Merenstein, Robert A. Rastall
    Abstract:

    The gut microbiota has been implicated in a range of diseases. This Review describes current understanding of probiotics and Prebiotics as a means to manage the microbiota to improve host health, including mechanisms of actions and potential for clinical use. The human gut microbiota is integral to health and is associated with a variety of diseases. Therapeutic and prophylactic effects of some probiotics and Prebiotics for a variety of gut-related disorders might be, at least in part, mediated through modification of the microbiota and/or its function. Probiotic microorganisms act via a variety of means, including modulation of immune function, production of organic acids and antimicrobial compounds, interaction with resident microbiota, interfacing with the host, improving gut barrier integrity and enzyme formation. Prebiotics are substrates that are selectively utilized by host microorganisms conferring a health benefit; prebiotic effects include defence against pathogens, immune modulation, mineral absorption, bowel function, metabolic effects and satiety. Use of some probiotics and Prebiotics is justified by robust assessments of efficacy, but not all products have been validated; the goal is evidence-based use by healthcare professionals. Probiotics and Prebiotics are microbiota-management tools for improving host health. They target gastrointestinal effects via the gut, although direct application to other sites such as the oral cavity, vaginal tract and skin is being explored. Here, we describe gut-derived effects in humans. In the past decade, research on the gut microbiome has rapidly accumulated and has been accompanied by increased interest in probiotics and Prebiotics as a means to modulate the gut microbiota. Given the importance of these approaches for public health, it is timely to reiterate factual and supporting information on their clinical application and use. In this Review, we discuss scientific evidence on probiotics and Prebiotics, including mechanistic insights into health effects. Strains of Lactobacillus , Bifidobacterium and Saccharomyces have a long history of safe and effective use as probiotics, but Roseburia spp., Akkermansia spp., Propionibacterium spp. and Faecalibacterium spp. show promise for the future. For Prebiotics, glucans and fructans are well proven, and evidence is building on the prebiotic effects of other substances (for example, oligomers of mannose, glucose, xylose, pectin, starches, human milk and polyphenols).

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016. In December 2016, a panel of experts in microbiology, nutrition and clinical research was convened by the International Scientific Association for Probiotics and Prebiotics to review the definition and scope of Prebiotics. Consistent with the original embodiment of Prebiotics, but aware of the latest scientific and clinical developments, the panel updated the definition of a prebiotic: a substrate that is selectively utilized by host microorganisms conferring a health benefit. This definition expands the concept of Prebiotics to possibly include non-carbohydrate substances, applications to body sites other than the gastrointestinal tract, and diverse categories other than food. The requirement for selective microbiota-mediated mechanisms was retained. Beneficial health effects must be documented for a substance to be considered a prebiotic. The consensus definition applies also to Prebiotics for use by animals, in which microbiota-focused strategies to maintain health and prevent disease is as relevant as for humans. Ultimately, the goal of this Consensus Statement is to engender appropriate use of the term 'prebiotic' by relevant stakeholders so that consistency and clarity can be achieved in research reports, product marketing and regulatory oversight of the category. To this end, we have reviewed several aspects of prebiotic science including its development, health benefits and legislation.

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016.

  • probiotics and Prebiotics prospects for public health and nutritional recommendations
    Annals of the New York Academy of Sciences, 2014
    Co-Authors: Mary Ellen Sanders, Glenn R Gibson, Seppo Salminen, Irene Lenoirwijnkoop, Daniel Merenstein, Bryon W Petschow, Max Nieuwdorp, Daniel J Tancredi, Christopher J Cifelli, Paul F Jacques
    Abstract:

    Probiotics and Prebiotics are useful interventions for improving human health through direct or indirect effects on the colonizing microbiota. However, translation of these research findings into nutritional recommendations and public health policy endorsements has not been achieved in a manner consistent with the strength of the evidence. More progress has been made with clinical recommendations. Conclusions include that beneficial cultures, including probiotics and live cultures in fermented foods, can contribute towards the health of the general population; Prebiotics, in part due to their function as a special type of soluble fiber, can contribute to the health of the general population; and a number of challenges must be addressed in order to fully realize probiotic and prebiotic benefits, including the need for greater awareness of the accumulated evidence on probiotics and Prebiotics among policy makers, strategies to cope with regulatory roadblocks to research, and high-quality human trials that address outstanding research questions in the field.

Mary Ellen Sanders - One of the best experts on this subject based on the ideXlab platform.

  • Probiotics and Prebiotics in intestinal health and disease: from biology to the clinic
    Nature Reviews Gastroenterology & Hepatology, 2019
    Co-Authors: Mary Ellen Sanders, Glenn R Gibson, Gregor Reid, Daniel J. Merenstein, Robert A. Rastall
    Abstract:

    The gut microbiota has been implicated in a range of diseases. This Review describes current understanding of probiotics and Prebiotics as a means to manage the microbiota to improve host health, including mechanisms of actions and potential for clinical use. The human gut microbiota is integral to health and is associated with a variety of diseases. Therapeutic and prophylactic effects of some probiotics and Prebiotics for a variety of gut-related disorders might be, at least in part, mediated through modification of the microbiota and/or its function. Probiotic microorganisms act via a variety of means, including modulation of immune function, production of organic acids and antimicrobial compounds, interaction with resident microbiota, interfacing with the host, improving gut barrier integrity and enzyme formation. Prebiotics are substrates that are selectively utilized by host microorganisms conferring a health benefit; prebiotic effects include defence against pathogens, immune modulation, mineral absorption, bowel function, metabolic effects and satiety. Use of some probiotics and Prebiotics is justified by robust assessments of efficacy, but not all products have been validated; the goal is evidence-based use by healthcare professionals. Probiotics and Prebiotics are microbiota-management tools for improving host health. They target gastrointestinal effects via the gut, although direct application to other sites such as the oral cavity, vaginal tract and skin is being explored. Here, we describe gut-derived effects in humans. In the past decade, research on the gut microbiome has rapidly accumulated and has been accompanied by increased interest in probiotics and Prebiotics as a means to modulate the gut microbiota. Given the importance of these approaches for public health, it is timely to reiterate factual and supporting information on their clinical application and use. In this Review, we discuss scientific evidence on probiotics and Prebiotics, including mechanistic insights into health effects. Strains of Lactobacillus , Bifidobacterium and Saccharomyces have a long history of safe and effective use as probiotics, but Roseburia spp., Akkermansia spp., Propionibacterium spp. and Faecalibacterium spp. show promise for the future. For Prebiotics, glucans and fructans are well proven, and evidence is building on the prebiotic effects of other substances (for example, oligomers of mannose, glucose, xylose, pectin, starches, human milk and polyphenols).

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016. In December 2016, a panel of experts in microbiology, nutrition and clinical research was convened by the International Scientific Association for Probiotics and Prebiotics to review the definition and scope of Prebiotics. Consistent with the original embodiment of Prebiotics, but aware of the latest scientific and clinical developments, the panel updated the definition of a prebiotic: a substrate that is selectively utilized by host microorganisms conferring a health benefit. This definition expands the concept of Prebiotics to possibly include non-carbohydrate substances, applications to body sites other than the gastrointestinal tract, and diverse categories other than food. The requirement for selective microbiota-mediated mechanisms was retained. Beneficial health effects must be documented for a substance to be considered a prebiotic. The consensus definition applies also to Prebiotics for use by animals, in which microbiota-focused strategies to maintain health and prevent disease is as relevant as for humans. Ultimately, the goal of this Consensus Statement is to engender appropriate use of the term 'prebiotic' by relevant stakeholders so that consistency and clarity can be achieved in research reports, product marketing and regulatory oversight of the category. To this end, we have reviewed several aspects of prebiotic science including its development, health benefits and legislation.

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016.

  • probiotics and Prebiotics prospects for public health and nutritional recommendations
    Annals of the New York Academy of Sciences, 2014
    Co-Authors: Mary Ellen Sanders, Glenn R Gibson, Seppo Salminen, Irene Lenoirwijnkoop, Daniel Merenstein, Bryon W Petschow, Max Nieuwdorp, Daniel J Tancredi, Christopher J Cifelli, Paul F Jacques
    Abstract:

    Probiotics and Prebiotics are useful interventions for improving human health through direct or indirect effects on the colonizing microbiota. However, translation of these research findings into nutritional recommendations and public health policy endorsements has not been achieved in a manner consistent with the strength of the evidence. More progress has been made with clinical recommendations. Conclusions include that beneficial cultures, including probiotics and live cultures in fermented foods, can contribute towards the health of the general population; Prebiotics, in part due to their function as a special type of soluble fiber, can contribute to the health of the general population; and a number of challenges must be addressed in order to fully realize probiotic and prebiotic benefits, including the need for greater awareness of the accumulated evidence on probiotics and Prebiotics among policy makers, strategies to cope with regulatory roadblocks to research, and high-quality human trials that address outstanding research questions in the field.

  • modulation of the microbial ecology of the human colon by probiotics Prebiotics and synbiotics to enhance human health an overview of enabling science and potential applications
    FEMS Microbiology Ecology, 2005
    Co-Authors: Robert A. Rastall, Glenn R Gibson, Harsharnjit S Gill, Fransisco Guarner, Todd R Klaenhammer, Gregor Reid, Ian Rowland, Mary Ellen Sanders
    Abstract:

    The application of probiotics and Prebiotics to the manipulation of the microbial ecology of the human colon has recently seen many scientific advances. The sequencing of probiotic genomes is providing a wealth of new information on the biology of these microorganisms. In addition, we are learning more about the interactions of probiotics with human cells and with pathogenic bacteria. An alternative means of modulating the colonic microbial community is by the use of prebiotic oligosaccharides. Increasing knowledge of the metabolism of Prebiotics by probiotics is allowing us to consider specifically targeting such dietary intervention tools at specific population groups and specific disease states.

Patrice D Cani - One of the best experts on this subject based on the ideXlab platform.

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016. In December 2016, a panel of experts in microbiology, nutrition and clinical research was convened by the International Scientific Association for Probiotics and Prebiotics to review the definition and scope of Prebiotics. Consistent with the original embodiment of Prebiotics, but aware of the latest scientific and clinical developments, the panel updated the definition of a prebiotic: a substrate that is selectively utilized by host microorganisms conferring a health benefit. This definition expands the concept of Prebiotics to possibly include non-carbohydrate substances, applications to body sites other than the gastrointestinal tract, and diverse categories other than food. The requirement for selective microbiota-mediated mechanisms was retained. Beneficial health effects must be documented for a substance to be considered a prebiotic. The consensus definition applies also to Prebiotics for use by animals, in which microbiota-focused strategies to maintain health and prevent disease is as relevant as for humans. Ultimately, the goal of this Consensus Statement is to engender appropriate use of the term 'prebiotic' by relevant stakeholders so that consistency and clarity can be achieved in research reports, product marketing and regulatory oversight of the category. To this end, we have reviewed several aspects of prebiotic science including its development, health benefits and legislation.

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016.

Kelly S Swanson - One of the best experts on this subject based on the ideXlab platform.

  • the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of synbiotics
    Nature Reviews Gastroenterology & Hepatology, 2020
    Co-Authors: Kelly S Swanson, Glenn R Gibson, Gregor Reid, Karen P Scott, Robert W Hutkins, Raylene A Reimer, Kristin Verbeke, Hannah D Holscher, Meghan B Azad, Nathalie M Delzenne
    Abstract:

    In May 2019, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened a panel of nutritionists, physiologists and microbiologists to review the definition and scope of synbiotics. The panel updated the definition of a synbiotic to "a mixture comprising live microorganisms and substrate(s) selectively utilized by host microorganisms that confers a health benefit on the host". The panel concluded that defining synbiotics as simply a mixture of probiotics and Prebiotics could suppress the innovation of synbiotics that are designed to function cooperatively. Requiring that each component must meet the evidence and dose requirements for probiotics and Prebiotics individually could also present an obstacle. Rather, the panel clarified that a complementary synbiotic, which has not been designed so that its component parts function cooperatively, must be composed of a probiotic plus a prebiotic, whereas a synergistic synbiotic does not need to be so. A synergistic synbiotic is a synbiotic for which the substrate is designed to be selectively utilized by the co-administered microorganisms. This Consensus Statement further explores the levels of evidence (existing and required), safety, effects upon targets and implications for stakeholders of the synbiotic concept.

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016. In December 2016, a panel of experts in microbiology, nutrition and clinical research was convened by the International Scientific Association for Probiotics and Prebiotics to review the definition and scope of Prebiotics. Consistent with the original embodiment of Prebiotics, but aware of the latest scientific and clinical developments, the panel updated the definition of a prebiotic: a substrate that is selectively utilized by host microorganisms conferring a health benefit. This definition expands the concept of Prebiotics to possibly include non-carbohydrate substances, applications to body sites other than the gastrointestinal tract, and diverse categories other than food. The requirement for selective microbiota-mediated mechanisms was retained. Beneficial health effects must be documented for a substance to be considered a prebiotic. The consensus definition applies also to Prebiotics for use by animals, in which microbiota-focused strategies to maintain health and prevent disease is as relevant as for humans. Ultimately, the goal of this Consensus Statement is to engender appropriate use of the term 'prebiotic' by relevant stakeholders so that consistency and clarity can be achieved in research reports, product marketing and regulatory oversight of the category. To this end, we have reviewed several aspects of prebiotic science including its development, health benefits and legislation.

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016.

Karen P Scott - One of the best experts on this subject based on the ideXlab platform.

  • the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of synbiotics
    Nature Reviews Gastroenterology & Hepatology, 2020
    Co-Authors: Kelly S Swanson, Glenn R Gibson, Gregor Reid, Karen P Scott, Robert W Hutkins, Raylene A Reimer, Kristin Verbeke, Hannah D Holscher, Meghan B Azad, Nathalie M Delzenne
    Abstract:

    In May 2019, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened a panel of nutritionists, physiologists and microbiologists to review the definition and scope of synbiotics. The panel updated the definition of a synbiotic to "a mixture comprising live microorganisms and substrate(s) selectively utilized by host microorganisms that confers a health benefit on the host". The panel concluded that defining synbiotics as simply a mixture of probiotics and Prebiotics could suppress the innovation of synbiotics that are designed to function cooperatively. Requiring that each component must meet the evidence and dose requirements for probiotics and Prebiotics individually could also present an obstacle. Rather, the panel clarified that a complementary synbiotic, which has not been designed so that its component parts function cooperatively, must be composed of a probiotic plus a prebiotic, whereas a synergistic synbiotic does not need to be so. A synergistic synbiotic is a synbiotic for which the substrate is designed to be selectively utilized by the co-administered microorganisms. This Consensus Statement further explores the levels of evidence (existing and required), safety, effects upon targets and implications for stakeholders of the synbiotic concept.

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016. In December 2016, a panel of experts in microbiology, nutrition and clinical research was convened by the International Scientific Association for Probiotics and Prebiotics to review the definition and scope of Prebiotics. Consistent with the original embodiment of Prebiotics, but aware of the latest scientific and clinical developments, the panel updated the definition of a prebiotic: a substrate that is selectively utilized by host microorganisms conferring a health benefit. This definition expands the concept of Prebiotics to possibly include non-carbohydrate substances, applications to body sites other than the gastrointestinal tract, and diverse categories other than food. The requirement for selective microbiota-mediated mechanisms was retained. Beneficial health effects must be documented for a substance to be considered a prebiotic. The consensus definition applies also to Prebiotics for use by animals, in which microbiota-focused strategies to maintain health and prevent disease is as relevant as for humans. Ultimately, the goal of this Consensus Statement is to engender appropriate use of the term 'prebiotic' by relevant stakeholders so that consistency and clarity can be achieved in research reports, product marketing and regulatory oversight of the category. To this end, we have reviewed several aspects of prebiotic science including its development, health benefits and legislation.

  • expert consensus document the international scientific association for probiotics and Prebiotics isapp consensus statement on the definition and scope of Prebiotics
    Nature Reviews Gastroenterology & Hepatology, 2017
    Co-Authors: Glenn R Gibson, Mary Ellen Sanders, Karen P Scott, Robert W Hutkins, Susan L Prescott, Raylene A Reimer, Seppo Salminen, Catherine Stanton, Kelly S Swanson, Patrice D Cani
    Abstract:

    With the continued interest in the role of the gut microbiota in health, attention has now turned to how to harness the microbiota for the benefit of the host. This Consensus Statement outlines the definition and scope of the term 'prebiotic' as determined by an expert panel convened by the International Scientific Association for Probiotics and Prebiotics in December 2016.

  • dietary Prebiotics current status and new definition
    Food Science & Technology Bulletin: Functional Foods, 2010
    Co-Authors: Glenn R Gibson, Robert A. Rastall, Karen P Scott, Kieran M Tuohy, Arland T Hotchkiss, Alix Dubertferrandon, Melanie G Gareau, Eileen F Murphy, Delphine M Saulnier, Gunnar Loh
    Abstract:

    AbstractIn November 2008, a group of scientists met at the 6th Meeting of the International Scientific Association of Probiotics and Prebiotics (ISAPP) in London, Ontario, Canada, to discuss the functionality of Prebiotics. As a result of this, it was concluded that the prebiotic field is currently